Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5ZLS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,406
Award facts
- Contract value 100% obligated
- $38,405.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,405.96 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, representing a specialized pharmaceutical procurement aligned with military and federal healthcare system needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical federal vendor supplying comprehensive medical products and pharmaceuticals to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to fulfill federal procurement requirements for both brand-name specialty medications and broader pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5ZLS?
SPE2DR26F5ZLS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F5ZLS worth?
The government has obligated $38,406 on SPE2DR26F5ZLS.
Is contract SPE2DR26F5ZLS an order under another contract?
Yes. SPE2DR26F5ZLS is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZLS competed?
The extent of competition for SPE2DR26F5ZLS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award